Bio-Ceramics for the Next 25 Years: Challenges and Opportunities

Abstract:

This paper examines challenges and opportunities for the field of bio-ceramics to achieve innovative solutions in two important areas of healthcare; regenerative medicine and personalized versus statistical-based diagnosis and therapy of individual patients. These opportunities are based upon use of new minimally invasive bio-photonics technology that can produce patient specific cell-based data to minimize costs, time and use of animals in developing and testing new bioactive ceramics. Changing the research culture is necessary to achieve significant improvements in the cost/benefit ratio of healthcare for aging populations. The approaches advocated in this paper have potential to achieve this cultural change.

• Periodical: Key Engineering Materials (Volume 587)
• Pages: 3-14
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.587.3
• Online since: November 2013
• Authors: Larry L. Hench
• Keywords: Bioactive Glass, Bio-Raman Spectroscopy, Diagnosis, Economics, Ethics, Gene Activation, Gene Regulation, Healthcare Revolution, Stem Cells, Survivability of Medical Devices, Tissue Regeneration

References

[1] D. Passigli, R. Sarkar, P. Paul, S. Saha, Ethics of end of life care: the need for improved communication among physicians, patients, and families. Ethics in Biology, Engineering and Medicine-An International Journal, 2(1): 45-69 (2011).

DOI: 10.1615/ethicsbiologyengmed.2011003417

[2] L.L. Hench, Bioceramics, Journal of the American Ceramic Society, 81(7): 1705-28 (1998).

[3] L.L. Hench, J. Wilson and D.C. Greenspan, Bioglass: A Short History and Bibliography, Journal of the Australian Ceramic Society, 40: 1–42 (2004).

[4] D. Callahan, What Kind of Life: The Limits of Medical Progress, Simon and Schuster, New York, NY, (1990).

[5] L.L. Hench, J.R. Jones, and M.B. Fenn, New Materials and Technologies for Healthcare: Imperial College Press, London, (2012).

[6] L.L. Hench, and J.M. Polak, Third-Generation Biomedical Materials, Science, 295, 1014-1017 (2002).

DOI: 10.1126/science.1067404

[7] L.L. Hench and J. Wilson, Eds. Clinical Performance of Skeletal Prostheses, Chapman and Hall, Ltd, London, (1996).

[8] L.L. Hench, Science, Faith and Ethics, London, UK: Imperial College Press, (2001).

[9] T.L. Beauchamp and L. Walters, eds. Contemporary Issues in Bioethics (3rd edition), California: Wadsworth Publishing Co. (1989).

[10] B. Hilton, First Do No Harm: Wrestling with the New Medicine's Life and Death Dilemmas Abingdon Press, Nashville, TN, (1991).

[11] P. S. Saha and S. Saha, Journal of Long-Term Effects of Medical Implants, 1.

[2] 127-134(1991).

[12] T.A. Raffin, J.N. Shurkin, and W. Sinkler III, Intensive Care: Facing the Critical Choices, New York: W.H. Freeman and Co. (1989).

DOI: 10.7748/ns.3.22.43.s60

[13] M.M. Uhlmann, Last Rights? Assisted Suicide and Euthanasia Debated, Michigan: W.B. Eardmanns Pub. Co. (1998).

[14] G.A. Larue, and R. Bayly, Long Term Care In An Aging Society, Amherst, NY: Prometheus Books, (1992).

[15] T. Kirkwood, Time of Our Lives, London, UK: Weidenfield and Nicolson, (1999).

[16] A. Gawande, Letting Go, The New Yorker, August 2, 36-49 (2010).

[17] Anon. Approaching Death: Improving Care at the End of Life, The Institute of Medicine, National Academy of Sciences Press, Washington, D.C. (1997).

[18] E.S. Place, N.D. Evans, and M.M. Stevens, Complexity in Biomaterials and Other Challenges in the Translation of Tissue Engineering, Nature Materials, 8, 457-470 (2009).

[19] I.D. Xynos, M.V.J. Hukkanen, J.J. Batten, I.D. Buttery, L.L. Hench, and J.M. Polak Ionic Dissolution Products of Bioactive Glass Increase Proliferation of Human Osteoblasts and Induced Insulin-like Growth Factor II mRNA Expression and Protein Synthesis, Biochem. Biophys. Res. Comm. 276: (2000).

DOI: 10.1006/bbrc.2000.3503

[20] I.D. Xynos, A.J. Edgar, L.D.K. Buttery, L.L. Hench, and J.M. Polak, Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution, Journal of Biomedical Materials Research, 55(2), 151-157 (2001).

DOI: 10.1002/1097-4636(200105)55:2<151::aid-jbm1001>3.0.co;2-d

[21] J.R. Jones, P.D. Lee, L.L. Hench, Hierarchical Porous Materials for Tissue Engineering, Philosophical Transactions of the Royal Society, 364, 263-281 (2006).

DOI: 10.1098/rsta.2005.1689

[22] .J.R. Jones, Review of bioactive glass: From Hench to hybrids, Acta Biomateriala http: /dx. doi. org/10. 1016/j. acbio. 2012. 08. 023, (2012).

[23] B.E. Ilharreborde, Morel, F. Fitoussi, A. Presedo, P. Souchet, G. Pennecot, and K. Mazda, Bioactive Glass as a Bone Substitute for Spinal Fusion in Adolescent Idiopathic Scoliosis: A Comparative Study with Iliac Crest Autograft. J. Pediatr, Ortho, 28, 347-351 (2008).

DOI: 10.1097/bpo.0b013e318168d1d4

[24] L.L. Hench (Ed), Introduction to Bioceramics, 2nd Edition, Imperial College Press, London, U.K., (2013).

[25] A. Leu, and J.K. Leach, Proangiogenic Potential of a Collagen/Bioactive Glass Substrate, Pharmaceutical Research, 25, 1222-1229 (2008).

DOI: 10.1007/s11095-007-9508-9

[26] A.A. Gorustovich, J. A. Roether, and A.R. Boccaccini, Effect of Bioactive Glasses on Angiogenesis: A Review of In Vitro and In Vivo Evidences, Tissue Engineering Part B, 16(2), 199-207 (2009).

DOI: 10.1089/ten.teb.2009.0416

[27] I. Notingher, S. Verrier, H. Romanska, A.E. Bishop, J.M. Polak, and L.L. Hench, In situ Characterisation of Living Cells by Raman Spectroscopy, Spectroscopy, 16, 43-51 (2002).

DOI: 10.1155/2002/408381

[28] .I. Notingher, I. Bisson, A.E. Bishop, W.L. Randle, J.M. Polak, and L.L. Hench, In-situ Spectral Monitoring of mRNA Translation in Embryonic Stem Cells During Differentiation In-Vitro Analytical Chemistry, 76, 3185-3193 (2004).

DOI: 10.1021/ac0498720

[29] I. Notingher, G. Jell, U. Lohbauer, V. Salih, and L.L. Hench, In-situ non-invasive Spectral Discrimination between Bone Cell Phenotypes used in Tissue Engineering Journal of Cellular Biochemistry, 92, 1180-1192 (2004).

DOI: 10.1002/jcb.20136

[30] I. Notingher, J. Selvakumaran, and L.L. Hench, New Detection System for Toxic Agents Based on Continuous Spectroscopic Monitoring of Living Cells Biosensors & Bioelectronics, 20, 780-789 (2004).

DOI: 10.1016/j.bios.2004.04.008

[31] I. Notingher, I. Bisson, J.M. Polak, and L.L. Hench, In Situ Spectroscopic Study of Nucleic Acids in Differentiating Embryonic Stem Cells, Vibrational Spectroscopy, 35, 199-203 (2004).

DOI: 10.1016/j.vibspec.2004.01.014

[32] I. Notingher, G. Jell, P.L. I. Notingher Bisson, O. Tsigkou, J.M. Polak, M.M. Stevens, and L.L. Hench, Multivariate Analysis of Raman Spectra for in Vitro Non-Invasive Studies of Living Cells, Journal of Molecular Structure, 744, 179-85 (2005).

DOI: 10.1016/j.molstruc.2004.12.046

[33] I. Notingher and L.L. Hench, Raman Microspectroscopy: A Non-Invasive Tool for Studies of Individual Living Cells in Vitro, Expert Review of Medical Devices, 3(2), 215-234 (2006).

DOI: 10.1586/17434440.3.2.215

[34] I. Notingher, C. Green, C. Dyer, and L.L. Hench, Discrimination Between Ricin and Sulfur Mustard Toxicity In Vitro Using Raman Spectroscopy, J. R. Soc. Interface, 1(1), 79-90 (2004).

DOI: 10.1098/rsif.2004.0008

[35] C. A. Owen, G. Jell, I. Notingher, and M.M. Stevens, In Vitro Toxicology Evaluation of Pharmaceuticals Using Raman Microspectroscopy, J. Cellular Biochemistry, 99(1), 178-186 (2006).

DOI: 10.1002/jcb.20884

[36] G. Jell, I. Notingher, O. Tsigkou, P. Notingher, J.M. Polak, L.L. Hench, M.M. Stevens, Bioactive Glass-Induced Osteoblast Differentiation: A Noninvasive Spectroscopic Study, Journal of Biomedical Materials Research Part A, 86A(1), 31-40 (2008).

DOI: 10.1002/jbm.a.31542

[37] C.A. Owen, J. Selvakumaran, I. Notingher, G. Jell, L.L. Hench, and M.M. Stevens, In Vitro Toxicology Evaluation of Pharmaceuticals Using Raman Micro-Spectroscopy, Journal of Cellular, Biochemistry, 99, 178-185 (2006).

DOI: 10.1002/jcb.20884

[38] E. Gentleman, R.J. Swain, N.D. Evans, S. Boonrungsiman, G. Jell, M. D. Ball, T.A.V. Sheen, M. Oven, A. Porter, and M.M. Stevens, Comparative Materials Differences Revealed in Engineered Bone as a Function of Cell-Specific Differentiation, Nature Materials. 8, 763-8 (2009).

DOI: 10.1038/nmat2505

[39] J.W. Chan, D.S. Taylor, T.D. Zwerdling, S.M. Lane, K. Ihara, and T. Huser, Micro-Raman Spectroscopy Detects Individual Neoplastic and Normal Hematopoietic Cells, Biophysical Journal, 90, 648-656 (2006).

DOI: 10.1529/biophysj.105.066761

[40] G. Pyrgiotakis, T.K. Bhowmick, and K. Finton, et al., Cell (A549)-Particle (Jasada Bhasma) Interactions Using Raman Spectroscopy, Biopolymers 89(6), 555-564 (2008).

DOI: 10.1002/bip.20947

[41] S. Wachsmann-Hogiu, T. Weeks, and T. Huser, Chemical analysis in vivo and in vitro by Raman spectroscopy- from single cells to humans, Current Opinion in Biotechnology, 20, 63-73 (2009).

DOI: 10.1016/j.copbio.2009.02.006

[42] C.H. Arnaud, Raman heads for the clinic, Chemical and Engineering News, 88(38), 8-12 (2010).

[43] M.B. Fenn, P. Xanthopoulos, G. Pyrgiotakis, S.R. Grobmyer, P.M. Pardalos, and L.L. Hench, Raman Spectroscopy for Clinical Oncology, Advances in Optical Technologies, Vol. 2011; 1-20. doi: 10. 1155/2011/213783, (2011).

DOI: 10.1155/2011/213783

[44] M.B. Fenn, V. Pappu, P. Georgeiv, and P.M. Pardalos, Raman spectroscopy utilizing Fisher-based feature selection combined with support vector machines for the characterization of breast cancer cell lines, Journal of Raman Spectroscopy (2013).

DOI: 10.1002/jrs.4309